OBAT.JK PT Brigit Biofarmaka Technologi Tbk
- Market cap
- IDR 163B
- P/E
- -
- P/B
- -
- ROE
- 21.2%
- Dividend yield
- 3.00%
- Fundamental score
- 1.8/5
Ratios use the latest price and the fiscal year ending Dec 2025.
Is OBAT.JK undervalued?
Graham numberThe Graham number of PT Brigit Biofarmaka Technologi Tbk cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PT Brigit Biofarmaka Technologi Tbk fundamental analysis
8 of 22 checks passedROE 2/2
High return on equity (21.2%), above 20%.
ROA 1/1
Return on assets (17.3%) is above the industry median (2.7%).
Profit Consistency 1/2
Profitable for 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-23.1%) is below the industry median (-17.0%).
Revenue Growth 0/2
Revenue did not grow over the past 3 years or is not reported.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (5.2%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 0/1
No interest expense reported.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book is negative or not available.
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield cannot be calculated.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 59.3%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
PT Brigit Biofarmaka Technologi Tbk stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PT Brigit Biofarmaka Technologi Tbk
PT Brigit Biofarmaka Technologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, and hair serum and powder, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. In addition, it provides lip gloss, …
Full company profilePT Brigit Biofarmaka Technologi Tbk financial statements
PT Brigit Biofarmaka Technologi Tbk annual financial statements
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 56.9B | 121B | 160B |
| Gross Profit | 22.7B | 57.9B | 62.9B |
| Operating Income | 14.2B | 38.2B | 33.1B |
| Net Income | 12.0B | 29.4B | 22.6B |
| EPS | 20 | 49 | 38 |
| Balance Sheet | |||
| Total Assets | 36.3B | 65.9B | 131B |
| Total Liabilities | 17.7B | 23.6B | 24.1B |
| Shareholders' Equity | 18.6B | 42.3B | 107B |
| Cash & Short-term Investments | 3.99B | 7.19B | 42.6B |
| Cash Flow | |||
| Operating Cash Flow | 14.0B | 13.0B | 23.7B |
| Capital Expenditure | 7.74B | 7.21B | 20.6B |
| Ratios | |||
| ROE | 64.3% | 69.6% | 21.2% |
| ROA | 33.0% | 44.7% | 17.3% |
| Net Profit Margin | 21.0% | 24.4% | 14.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
PT Brigit Biofarmaka Technologi Tbk dividends
- Dividend yield
- 3.00%
- Forward dividend
- 7.55 IDR
- Payout ratio
- 59.3%
- Ex-dividend date
- May 22, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 13.4B | 22 | 59.3% |
| 2024 | - | - | - |
| 2023 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns PT Brigit Biofarmaka Technologi Tbk
- Insiders 75.47%
- Institutions 0.29%
- Public & others 24.24%
- Shares outstanding 680M
- Free float 118M
PT Brigit Biofarmaka Technologi Tbk company profile
- Company name
- PT Brigit Biofarmaka Technologi Tbk
- Ticker
- OBAT.JK
- Exchange
- Jakarta Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Employees
- 17
- Fiscal year end
- December
- Address
- Rejosari RT.01 RW.07, Sukoharjo, Indonesia, 57561
- Phone
- 62 27 1599 2141
- Website
- brigit.co.id
About PT Brigit Biofarmaka Technologi Tbk
PT Brigit Biofarmaka Technologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, and hair serum and powder, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. In addition, it provides lip gloss, cushion, foundation, eyeliner, and blush on balm. The company was founded in 2015 and is based in Sukoharjo, Indonesia.
PT Brigit Biofarmaka Technologi Tbk management
5- Mr. Is HeriyantoPresident Director · born 1979
- Ms. Atik SetyaningsihDirector of Finance & Director · born 1991
- Mr. Angga Arie WibowoDirector of Operations & Director · born 1987
- Esti Kurnia SandyHead of Internal Audit
- Toufin Noor PrambudiCompany Secretary